Home Newsfeeds Centessa Pharmaceuticals Q3 EPS $(0.57) Down From $(0.45) YoY

Centessa Pharmaceuticals Q3 EPS $(0.57) Down From $(0.45) YoY

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.

News
Tech

MacBook With A Foldable Display? Apple Is Reportedly Planning One

By Rounak Jain

July 7, 10:06 AM

Apple is reportedly in talks with display suppliers for a foldable MacBook, including from companies like LG Display and Samsung Display.

AAPL

Wells Fargo Maintains Equal-Weight on Booking Holdings, Raises Price Target to $2400

By Benzinga Newsdesk

January 19, 8:57 AM

Wells Fargo analyst Brian Fitzgerald maintains Booking Holdings (NASDAQ:BKNG) with a Equal-Weight and raises the price target from $2050 to $2400.

BKNG

Martin Midstream Partners And 3 Other Stocks Under $5 Insiders Are Buying

By Lisa Levin

September 6, 9:25 AM

The Dow Jones closed lower by around 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BRGC